HSCS HeartSciences Inc.
Finance Services · Nasdaq · SEC CIK 1468492 · Fiscal year ends 04/30
Financial factors as of 2026-07-31 (2027Q1), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q12026-07-31 | 2026Q4*2026-04-30 | 2026Q32026-01-31 | 2025Q22025-10-31 | 2025Q12025-07-31 | 2025Q4*2025-04-30 | 2025Q32025-01-31 | 2025Q22024-10-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $2,100 | $0 | $0 | $2,419 | $1,900 | $4,350 | $0 | — |
| Cost of revenue | $760 | $0 | $0 | $1,008 | $760 | $1,880 | $0 | — |
| Gross profit | $1,340 | $0 | $0 | $1,411 | $1,140 | $2,470 | $0 | — |
| R&D expense | $906,629 | $476,205 | $638,575 | $727,026 | $997,206 | $929,091 | $1.03M | $1.20M |
| SG&A expense | $2.03M | $2.06M | $1.29M | $1.35M | $878,053 | $993,778 | $1.34M | $786,068 |
| Operating income | -$2.94M | -$2.54M | -$1.93M | -$2.07M | -$1.87M | -$1.92M | -$2.37M | -$1.99M |
| Interest expense | $235,261 | $228,310 | $61,509 | $279,534 | $183,688 | $180,852 | $179,477 | $117,598 |
| Net income | -$3.17M | -$2.75M | -$1.99M | -$2.35M | -$2.05M | -$2.09M | -$2.54M | -$2.08M |
| EBITDA | -$2.93M | -$2.53M | -$1.92M | -$2.07M | -$1.87M | -$1.91M | -$2.37M | -$1.97M |
| EPS (basic) | -0.86 | — | -0.63 | -0.85 | -1.58 | — | -2.57 | -2.27 |
| EPS (diluted) | — | — | — | -0.85 | -1.58 | — | -2.57 | -2.27 |
| Dividends declared per share | 0.00 | 0.00 | — | — | — | — | — | — |
| Weighted avg. shares (diluted) | — | — | — | 2.78M | 1.30M | — | 986,057 | 917,445 |
| Balance sheet | ||||||||
| Cash & equivalents | $29,906 | $1.66M | $3.40M | $1.95M | $2.79M | $1.10M | $2.60M | $4.05M |
| Receivables | — | — | $0 | — | — | $4,350 | — | — |
| Inventory | $402,989 | $655,629 | $657,285 | $657,285 | $649,507 | $650,267 | $652,147 | $652,907 |
| Current assets | $811,768 | $2.58M | $5.10M | $3.79M | $4.42M | $2.17M | $3.63M | $5.69M |
| PP&E, net | $32,980 | $39,312 | $46,070 | $52,986 | $56,438 | $63,549 | $71,062 | $77,069 |
| Intangibles | $1.66M | $1.66M | $1.66M | $1.63M | $1.62M | $1.62M | $1.61M | $1.59M |
| Total assets | $3.74M | $5.26M | $7.55M | $6.00M | $6.44M | $4.22M | $5.70M | $7.78M |
| Current liabilities | $5.63M | $4.86M | $4.27M | $1.57M | $3.01M | $3.70M | $3.57M | $3.30M |
| Total liabilities | $5.77M | $5.04M | $4.90M | $1.81M | $3.30M | $4.02M | $3.92M | $3.76M |
| Shareholders' equity | -$2.03M | $226,060 | $2.65M | $4.18M | $3.14M | $205,171 | $1.79M | $4.02M |
| Shares outstanding | 3.90M | 3.19M | 3.18M | 3.07M | 2.28M | 1.12M | 1.03M | 947,821 |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.32M | -$1.68M | -$1.46M | -$2.33M | -$1.95M | -$1.59M | -$1.62M | -$2.18M |
| Capital expenditure | — | $0 | -$9,476 | — | — | $0 | $0 | — |
| Free cash flow | — | -$1.68M | -$1.45M | — | — | -$1.59M | -$1.62M | — |
| Investing cash flow | -$280,107 | $0 | -$27,868 | -$15,770 | -$814 | -$7,812 | -$15,701 | -$5,842 |
| Financing cash flow | -$27,942 | -$63,673 | $2.94M | $1.51M | $3.65M | $100,028 | $180,187 | $1.90M |
| Depreciation & amortization | $6,332 | $6,758 | $6,916 | $7,006 | $7,111 | $7,513 | $6,007 | $12,215 |
| Stock-based compensation | $738,889 | $324,841 | $376,100 | $436,884 | $174,558 | $95,945 | $54,824 | $44,561 |
Free plan shows the latest 8 periods; Pro shows all 21 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.